Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers.

Laddha SV, Nayak S, Paul D, Reddy R, Sharma C, Jha P, Hariharan M, Agrawal A, Chowdhury S, Sarkar C, Mukhopadhyay A.

Biol Direct. 2013 Apr 24;8:10. doi: 10.1186/1745-6150-8-10.

PMID:
23618224
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers.

Hua Y, Larsen N, Kalyana-Sundaram S, Kjems J, Chinnaiyan AM, Peter ME.

BMC Genomics. 2013 Mar 15;14:179. doi: 10.1186/1471-2164-14-179.

PMID:
23497354
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Analysis of serum genome-wide microRNAs for breast cancer detection.

Wu Q, Wang C, Lu Z, Guo L, Ge Q.

Clin Chim Acta. 2012 Jul 11;413(13-14):1058-65. doi: 10.1016/j.cca.2012.02.016. Epub 2012 Feb 23.

PMID:
22387599
[PubMed - indexed for MEDLINE]
4.

MicroRNA expression signatures of bladder cancer revealed by deep sequencing.

Han Y, Chen J, Zhao X, Liang C, Wang Y, Sun L, Jiang Z, Zhang Z, Yang R, Chen J, Li Z, Tang A, Li X, Ye J, Guan Z, Gui Y, Cai Z.

PLoS One. 2011 Mar 28;6(3):e18286. doi: 10.1371/journal.pone.0018286.

PMID:
21464941
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.

Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.

Breast Cancer Res. 2012 May 14;14(3):R77.

PMID:
22583478
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.

Lee H, Park CS, Deftereos G, Morihara J, Stern JE, Hawes SE, Swisher E, Kiviat NB, Feng Q.

World J Surg Oncol. 2012 Aug 27;10:174.

PMID:
22925189
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Genome-wide screen for aberrantly expressed miRNAs reveals miRNA profile signature in breast cancer.

Guo L, Zhao Y, Yang S, Cai M, Wu Q, Chen F.

Mol Biol Rep. 2013 Mar;40(3):2175-86. doi: 10.1007/s11033-012-2277-5. Epub 2012 Nov 30.

PMID:
23196705
[PubMed - indexed for MEDLINE]
8.

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.

van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.

Breast Cancer Res. 2012 Feb 21;14(1):R34.

PMID:
22353773
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.

Creighton CJ, Hernandez-Herrera A, Jacobsen A, Levine DA, Mankoo P, Schultz N, Du Y, Zhang Y, Larsson E, Sheridan R, Xiao W, Spellman PT, Getz G, Wheeler DA, Perou CM, Gibbs RA, Sander C, Hayes DN, Gunaratne PH; Cancer Genome Atlas Research Network.

PLoS One. 2012;7(3):e34546. doi: 10.1371/journal.pone.0034546. Epub 2012 Mar 29.

PMID:
22479643
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.

Sarver AL, Thayanithy V, Scott MC, Cleton-Jansen AM, Hogendoorn PC, Modiano JF, Subramanian S.

Orphanet J Rare Dis. 2013 Jan 11;8:7. doi: 10.1186/1750-1172-8-7.

PMID:
23311495
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

MicroRNA expression profiling of male breast cancer.

Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, Rosenberg A.

Breast Cancer Res. 2009;11(4):R58. doi: 10.1186/bcr2348. Epub 2009 Aug 10.

PMID:
19664288
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.

Furuta M, Kozaki K, Tanimoto K, Tanaka S, Arii S, Shimamura T, Niida A, Miyano S, Inazawa J.

PLoS One. 2013;8(3):e60155. doi: 10.1371/journal.pone.0060155. Epub 2013 Mar 27.

PMID:
23544130
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.

Aydoğdu E, Katchy A, Tsouko E, Lin CY, Haldosén LA, Helguero L, Williams C.

Carcinogenesis. 2012 Aug;33(8):1502-11. doi: 10.1093/carcin/bgs161. Epub 2012 May 4.

PMID:
22562546
[PubMed - indexed for MEDLINE]
Free Article
14.

Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene.

Tanic M, Yanowsky K, Rodriguez-Antona C, Andrés R, Márquez-Rodas I, Osorio A, Benitez J, Martinez-Delgado B.

PLoS One. 2012;7(6):e38847. doi: 10.1371/journal.pone.0038847. Epub 2012 Jun 11.

PMID:
22701724
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.

Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R.

Int J Cancer. 2013 Apr 1;132(7):1633-45. doi: 10.1002/ijc.27840. Epub 2012 Oct 17.

PMID:
22987275
[PubMed - indexed for MEDLINE]
16.

Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.

Zaravinos A, Radojicic J, Lambrou GI, Volanis D, Delakas D, Stathopoulos EN, Spandidos DA.

J Urol. 2012 Aug;188(2):615-23. doi: 10.1016/j.juro.2012.03.122. Epub 2012 Jun 15.

PMID:
22704449
[PubMed - indexed for MEDLINE]
17.

Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.

Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, Enokida H.

Oncotarget. 2012 Jan;3(1):44-57.

PMID:
22294552
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.

Gravgaard KH, Lyng MB, Laenkholm AV, Søkilde R, Nielsen BS, Litman T, Ditzel HJ.

Breast Cancer Res Treat. 2012 Jul;134(1):207-17. doi: 10.1007/s10549-012-1969-9.

PMID:
22294488
[PubMed - indexed for MEDLINE]
19.

Potential role of miR-9 and miR-223 in recurrent ovarian cancer.

Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, O' Leary J.

Mol Cancer. 2008 Apr 28;7:35. doi: 10.1186/1476-4598-7-35.

PMID:
18442408
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

Zhong S, Li W, Chen Z, Xu J, Zhao J.

Gene. 2013 Nov 15;531(1):8-14. doi: 10.1016/j.gene.2013.08.062. Epub 2013 Aug 29.

PMID:
23994196
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk